Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation.

Cancers (Basel) · 2022 · PMC9323743 · PMID 35884368

Europe PMC DOI

hedged sentence

0.3100

closest p · 6.2× alpha

0.3100

boldest claim

The sentences

did not reach statistical significancep = 0.31not close (p > 0.1)

However, this time difference did not reach statistical significance ( p = 0.31).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.